Innovator IBD ETF Leaders ETF
LDRS
LDRS was delisted on the 13th of August, 2021.
0 hedge funds and large institutions have $0 invested in Innovator IBD ETF Leaders ETF in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $769K → $0 (-$769K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RWM
RMG Wealth Management
Platteville,
Wisconsin
|
-$769K |
LDRS Hedge Fund Activity: Q1 2026 in Review
0 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q1 2026, worth a combined $0 — down 100% from $769K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of LDRS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was RMG Wealth Management, exiting entirely with an estimated $769K sold.
- 0 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q1 2026, down from 1 in Q4 2025.
- Funds reported $0 of Innovator IBD ETF Leaders ETF stock for Q1 2026, down 100% quarter-over-quarter.
- 0 funds opened new Innovator IBD ETF Leaders ETF positions in Q1 2026 and 1 closed out, a net change of -1 holder.
- The largest Innovator IBD ETF Leaders ETF seller in Q1 2026 was RMG Wealth Management, an estimated $769K sold.
Based on aggregated 13F filings for Q1 2026.